Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project

Publisher： Karger

E-ISSN： 1421-9913|65|2|59-67

ISSN： 0014-3022

Source： European Neurology, Vol.65, Iss.2, 2011-01, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records

By  

Neuroepidemiology, Vol. 48, Iss. 3-4, 2017-07 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

Efficacy of Disease-Modifying Therapies in Relapsing Remitting Multiple Sclerosis: A Systematic Comparison

By  

European Neurology, Vol. 60, Iss. 1, 2008-04 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

Long-Term Adherence to Interferon β Therapy in Relapsing-Remitting Multiple Sclerosis

By  

European Neurology, Vol. 59, Iss. 3-4, 2007-11 ,pp. : 131-135

Karger

Access to resources Recommend Favorite

Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies

By  

European Neurology, Vol. 70, Iss. 1-2, 2013-05 ,pp. : 35-41

Karger

Access to resources Recommend Favorite

Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade

By  

European Neurology, Vol. 75, Iss. 5-6, 2016-06 ,pp. : 274-281

Karger

Access to resources Recommend Favorite